These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 30789300)

  • 1. What are the psychological effects of using synthetic cannabinoids? A systematic review.
    Akram H; Mokrysz C; Curran HV
    J Psychopharmacol; 2019 Mar; 33(3):271-283. PubMed ID: 30789300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Pharmacologic and Clinical Effects of Illicit Synthetic Cannabinoids.
    White CM
    J Clin Pharmacol; 2017 Mar; 57(3):297-304. PubMed ID: 27610597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of cannabinoid 1 receptor compounds on memory: a meta-analysis and systematic review across species.
    Borgan F; Beck K; Butler E; McCutcheon R; Veronese M; Vernon A; Howes OD
    Psychopharmacology (Berl); 2019 Nov; 236(11):3257-3270. PubMed ID: 31165913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthetic cannabinoid use among college students.
    Mathews EM; Jeffries E; Hsieh C; Jones G; Buckner JD
    Addict Behav; 2019 Jun; 93():219-224. PubMed ID: 30772774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Synthetic Cannabinoids Phenomenon.
    Karila L; Benyamina A; Blecha L; Cottencin O; Billieux J
    Curr Pharm Des; 2016; 22(42):6420-6425. PubMed ID: 27655416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of synthetic cannabinoids on executive function.
    Cohen K; Kapitány-Fövény M; Mama Y; Arieli M; Rosca P; Demetrovics Z; Weinstein A
    Psychopharmacology (Berl); 2017 Apr; 234(7):1121-1134. PubMed ID: 28160034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Short-and long-term effects of cannabinoids on memory, cognition and mental illness].
    Sagie S; Eliasi Y; Livneh I; Bart Y; Monovich E
    Harefuah; 2013 Dec; 152(12):737-41, 751. PubMed ID: 24483000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthetic cannabinoid JWH-018 and psychosis: an explorative study.
    Every-Palmer S
    Drug Alcohol Depend; 2011 Sep; 117(2-3):152-7. PubMed ID: 21316162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spicing Up Pharmacology: A Review of Synthetic Cannabinoids From Structure to Adverse Events.
    Davidson C; Opacka-Juffry J; Arevalo-Martin A; Garcia-Ovejero D; Molina-Holgado E; Molina-Holgado F
    Adv Pharmacol; 2017; 80():135-168. PubMed ID: 28826533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single and combined effects of plant-derived and synthetic cannabinoids on cognition and cannabinoid-associated withdrawal signs in mice.
    Myers AM; Siegele PB; Foss JD; Tuma RF; Ward SJ
    Br J Pharmacol; 2019 May; 176(10):1552-1567. PubMed ID: 29338068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The adverse health effects of synthetic cannabinoids with emphasis on psychosis-like effects.
    van Amsterdam J; Brunt T; van den Brink W
    J Psychopharmacol; 2015 Mar; 29(3):254-63. PubMed ID: 25586398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurocognition and subjective experience following acute doses of the synthetic cannabinoid JWH-018: a phase 1, placebo-controlled, pilot study.
    Theunissen EL; Hutten NRPW; Mason NL; Toennes SW; Kuypers KPC; de Sousa Fernandes Perna EB; Ramaekers JG
    Br J Pharmacol; 2018 Jan; 175(1):18-28. PubMed ID: 29164599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for the Risks and Consequences of Adolescent Cannabis Exposure.
    Levine A; Clemenza K; Rynn M; Lieberman J
    J Am Acad Child Adolesc Psychiatry; 2017 Mar; 56(3):214-225. PubMed ID: 28219487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Effects of Cannabinoids on Executive Functions: Evidence from Cannabis and Synthetic Cannabinoids-A Systematic Review.
    Cohen K; Weinstein A
    Brain Sci; 2018 Feb; 8(3):. PubMed ID: 29495540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case of cannabinoid hyperemesis syndrome caused by synthetic cannabinoids.
    Hopkins CY; Gilchrist BL
    J Emerg Med; 2013 Oct; 45(4):544-6. PubMed ID: 23890687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "Spice" and "K2" herbal highs: a case series and systematic review of the clinical effects and biopsychosocial implications of synthetic cannabinoid use in humans.
    Gunderson EW; Haughey HM; Ait-Daoud N; Joshi AS; Hart CL
    Am J Addict; 2012; 21(4):320-6. PubMed ID: 22691010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human Laboratory Studies on Cannabinoids and Psychosis.
    Sherif M; Radhakrishnan R; D'Souza DC; Ranganathan M
    Biol Psychiatry; 2016 Apr; 79(7):526-38. PubMed ID: 26970363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain Imaging Studies on the Cognitive, Pharmacological and Neurobiological Effects of Cannabis in Humans: Evidence from Studies of Adult Users.
    Weinstein A; Livny A; Weizman A
    Curr Pharm Des; 2016; 22(42):6366-6379. PubMed ID: 27549374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-exposure of cannabinoids with amphetamines and biological, behavioural and health outcomes: a scoping review of animal and human studies.
    Daldegan-Bueno D; Maia LO; Glass M; Jutras-Aswad D; Fischer B
    Psychopharmacology (Berl); 2022 May; 239(5):1211-1230. PubMed ID: 34613429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabis and cannabinoids: pharmacology and rationale for clinical use.
    Pertwee RG
    Forsch Komplementarmed; 1999 Oct; 6 Suppl 3():12-5. PubMed ID: 10575283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.